ARTICLE
14 September 2017

Publication Of National Audit Office Study On Managing The Costs Of Clinical Negligence In Trusts

CC
Clyde & Co

Contributor

Clyde & Co  logo
Clyde & Co is a leading, sector-focused global law firm with 415 partners, 2200 legal professionals and 3800 staff in over 50 offices and associated offices on six continents. The firm specialises in the sectors that move, build and power our connected world and the insurance that underpins it, namely: transport, infrastructure, energy, trade & commodities and insurance. With a strong focus on developed and emerging markets, the firm is one of the fastest growing law firms in the world with ambitious plans for further growth.
The National Audit Office (NAO) has today published its study ‘Managing the costs of clinical negligence in trusts' focusing on work undertaken by the Department of Health and NHS Resolution.
UK Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

The National Audit Office (NAO) has today published its study 'Managing the costs of clinical negligence in trusts' focusing on work undertaken by the Department of Health and NHS Resolution (formerly the NHS Litigation Authority). The study can be found here: NAO VFM study.

The cost of clinical negligence in trusts is significant and rising fast. The study concludes that NHS Resolution has taken effective action to control costs and has achieved significant savings for the taxpayer from contesting unmeritorious or excessive claims and legal charges.

The NAO summarises what NHS Resolution is doing to take further action to tackle the biggest drivers of cost increases within its control, and highlights the publication of its five year strategy in April 2017 which set out its plans on safety and learning and in engaging with NHS trusts in the management of claims. This includes the introduction from April 2017 of an 'early notification' scheme for babies born with cerebral palsy, encouraging trusts to report these cases early and providing support to trusts in engaging with affected families.

The study finds that some of the biggest factors influencing costs fall within the remit of more than one government department or are largely outside the health system's control. These include developments in the legal market and the increasing level of damages awarded for high value claims. The study also notes that NHS Resolution and the Department of Health, working with others, including the Ministry of Justice, have identified many of the factors contributing to the rising costs of clinical negligence.

The NAO concludes with a recommendation for a cross-government strategy on the cost of clinical negligence for trusts which identifies the balance to be struck between providing patients with access to justice and access to health services.

This is a useful and balanced report containing valuable insights into the challenge of rising clinical negligence costs.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More